TABLE 2—

Use of Highly Active Antiretroviral Therapy Among Subgroups of Male-to-Female Transgender Persons as Compared With Subgroups of Control Subjects Who Are HIV Positive

Taking Highly Active Antiretroviral Therapy	Male-to-Female Transgender Persons, %	Control Group, %	P
Age < 41 ya	61	76	.063
< 13 y educationb	59	79	.010
African Americans	56	84	.001
Whites	60	82	NS
Living in welfare hotel or shelter	53	72	NS
Ever incarcerated	63	76	.051
Daily alcohol use, past 3 months	55	55	NS

Note. Analyses were restricted to subgroups (i.e., African American male-to-female transgender persons and African American control subjects). NS = results that were not statistically significant.

^aAge was dichotomized by dividing the sample into 2 groups according to the median (41 y).

^bEducation was dichotomized by dividing the sample according to the median (13 y).